Join a 8 week revolutionary chronic pain treatment study

Take part in a no-cost, physician-monitored study evaluating a VNS device. Help advance medical science while potentially finding relief for your condition.

Study overview

Your participation

This study consist of: 10 On-site visits (1h each) 4 Video calls (20-45min each)

Compensation

Participants receive $150 per completed visit, up to $2100 total for the full study.

Timelines

Enrolment for this study closes on September 15, 2025. Total duration of study can vary between 6 to 8 weeks.

Study sites

We have set up 8 study sites in the US. We will offer you travel assistance.

Next steps

Step 1: Pre-screening

Assess your eligibility for this study with a quick questionnaire

Step 2: Screening

Remote video-call, 20 min

Step 3: Baseline assessment

Site visit, 60 min

Step 4: Final eligibility

Site visit, 60 min

Patient Stories

Robert

Cardiovascular Research Trial

"The cardiovascular clinical trial I participated in provided me with access to the latest treatments before they became widely available. The through screening process and ongoing support gave me confidence in the study."

Maria

Autoimmune Treatment Study

"Joining this crinical trial for my autoimmune condition was life-changing. The research team's expertise and dedication were evident from day one. I received personalized care and monitoring that exceeded my expectations."

David

Migraine Prevention Trial

"The migraine study I participated in provided me with access to innovative treatments that significantly reduced my symptoms. The study coordinators were professional and made me feel comfortable throughout the process."

Robert

Cardiovascular Research Trial

"The cardiovascular clinical trial I participated in provided me with access to the latest treatments before they became widely available. The through screening process and ongoing support gave me confidence in the study."

Maria

Autoimmune Treatment Study

"Joining this crinical trial for my autoimmune condition was life-changing. The research team's expertise and dedication were evident from day one. I received personalized care and monitoring that exceeded my expectations."

David

Migraine Prevention Trial

"The migraine study I participated in provided me with access to innovative treatments that significantly reduced my symptoms. The study coordinators were professional and made me feel comfortable throughout the process."

Who is this study for?

You may be eligible if you meet the following requirements:
Gender
Female at birth
Age
18-50 years old
Smoker
No

Diagnosed with treatment-resistant depression (failed at least 2 antidepressant medications)

Current depression severity score ≥20 on Hamilton Depression Rating Scale

Do not have any prior VNS device implantation

No plans for MRI scans during study period (VNS devices have MRI restrictions)

Have been diagnosed with ovarian cancer with or without treatment for ovarian cancer

Do you think you’re eligible?

Complete a quick questionnaire to assess if you meet the study criteria and start benefitting from this innovative treatment.

Find a clinic near you

Clinics near you:

Start by entering a location or use your current position.

Your questions answered

Check eligibility